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Nerve agents are highly toxic organophosphorus (OP) compounds. They inhibit acetylcholinesterase 
(AChE), an enzyme that hydrolyses acetycholine (ACh) in the nervous system. Pathophysiological changes 
caused by OP poisonings are primarily the consequence of surplus ACh on cholinergic receptors and in 
the central nervous system. Standard treatment of OP poisoning includes combined administration of 
carbamates, atropine, oximes and anticonvulsants. In order to improve therapy, new compounds have been 
synthesised and tested. Tenocyclidine (TCP) and its adamantane derivative 1-[2-(2-thienyl)-2-adamantyl] 
morpholine (TAMORF) have shown interesting properties against soman poisoning. In this study, we 
developed a qualitative GC-MS method to measure elimination of TCP and TAMORF through rat urine in 
order to learn more about the mechanisms through which TCP protects an organism from OP poisoning and 
to determine the duration of this protective effect. GC-MS showed that six hours after treatment with TCP, 
rat urine contained only its metabolite 1-thienylcyclohexene, while urine of rats treated with TAMORF 
contained both TAMORF and its metabolites.
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Organophosphorous (OP) compounds are highly 
toxic substances widely used in agriculture as 
pesticides. Very few of them are prescribed to treat 
cholinergic disorders in humans (1-4). The most toxic 
organophosphates sarin, soman, tabun, and VX have 
long been used as nerve agents in chemical warfare 
and terrorist actions (1, 2, 5, 6). Due to irreversible 
inhibition of the enzyme acetylcholinesterase 
(AChE), OP poisoning primarily leads to extracellular 
accumulation of neurotransmitter acetylcholine 
(ACh) at muscarinic receptors of the peripheral and 
central nervous system, causing a host of symptoms 
including hypersalivation, lacrimation, diarrhoea, 
tremor, respiratory distress, epileptiform convulsions, 
and heart failure. Signs are dose-dependent, leading to 
severe incapacitation and rapid death (1, 2, 7-9). The 
current standard treatment of OP poisoning includes 
pre-treatment with reversible AChE-inhibitors such 
as carbamate pyridostigmine bromide or  combined 
therapy with oximes (cholinesterase reactivators), 
atropine sulphate (a muscarinic cholinergic receptor 
antagonist), and benzodiazepines (anticonvulsants). 
However, standard treatment leaves much to be desired 
since none of the standard oximes can be regarded as 
a universally suitable reactivator of AChE. In case of 
soman poisoning, reinhibition of AChE is faster than 
reactivation, and oxime therapy is ineffective due to 
the “aging” of the enzyme, which makes reactivation 
impossible (2, 10-13).
To improve therapy against OP poisoning, 
new compounds have been synthesised and tested. 
Tenocyclidine (TCP, Figure 1), derivative of 
phencyclidine (PCP), has proven itself as an effective 
adjuvant therapy to atropine, diazepam, and HI-6 
(oxime) against soman poisoning in guinea pigs (1, 
14).
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It seems that the therapeutic effect of TCP is 
related to the excitatory amino acid glutamate 
neurotransmission and especially to N-methyl-
D-aspartate (NMDA) receptors, which, just like 
muscarinic receptors, are involved in soman-induced 
seizures (1,14-16). However, what limits TCP use is 
its toxicity (2). Škare et al. (1) used three adamantyl 
TCP derivatives, 1-[2-(2-thienyl)-2-adamantyl] 
piperidine (TAPIP), 1-[2-(2-thienyl)-2-adamantyl] 
pyrolidine (TAPIR), and 1-[2-(2-thienyl)-2-adamantyl] 
morpholine (TAMORF), assuming that replacing the 
cyclohexyl group of TCP with an adamantly group 
and piperidine, pyrolidine, or morpholine would 
reduce TCP toxicity and improve its pharmacological 
properties. When adamantyl derivatives were 
administered with atropine and HI-6 to mice poisoned 
with soman, TAMORF (Figure 2) showed the best 
antagonising effect (1). Pretreatment with TAMORF 
protected animals from the lethal effects of soman and 
eliminated most of the soman-induced signs of toxicity 
in poisoned rats (2). Both TCP and TAMORF have 
shown low genotoxicity (2, 17, 18). Besides antidotal 
efﬁ ciency, TCP and TAMORF showed interesting 
radioprotective properties (17).
The aim of this study was to learn more about 
the pathways through which TCP and its adamantyl 
derivatives protect against OP poisoning. For this 
purpose we developed a gas chromatography - mass 
spectrometry (GC-MS) method to establish TCP and 
TAMORF elimination through urine in rats six hours 
after treatment, as this information speaks about the 
duration of their antidotal activity.
MATERIALS AND METHODS
Pure TCP and TAMORF
TCP and TAMORF were prepared according to a 
procedure reported earlier (1). They were identiﬁ ed 
and their purity determined at Ruđer Bošković 
Institute (Zagreb, Croatia) using spectroscopic 
techniques (infrared spectroscopy, 1H and 13C nuclear 
magnetic resonance and mass specrometry) and 
elemental analysis.
Mass spectra of TCP and TAMORF powders were 
scanned for later comparison with the mass spectra of 
signals from the GC-MS chromatogram.
Mass spectrometer and operational conditions
The instrument consisted of a quadrupole MS (QP-
2010, Shimadzu, Japan), PC, and a printer. Ionization 
mode was electron impact (EI), ion source temperature 
200 °C, inlet temperature range 40 °C  to 200 °C with 
the rate of 20 °C min-1; the acquisition mode was scan 
and the scanning rate was 40.00 m/z to 550.00 m/z. 
Standard chloroform solutions of TCP and 
TAMORF
2.00 mg of TCP or TAMORF was added to 1.00 mL 
of chloroform (p. a., Merck, Germany), and shaken in 
an ultrasonic bath (Branson 5210, Bransonic, USA) for 
10 min. The solutions were then ﬁ ltered (Chromaﬁ l 
RC 45/15 MS, Macherey-Nagel, Germany) into 
analytical vials and analysed with GC-MS.
Extraction of TCP and TAMORF from spiked rat 
urine samples
2.00 mg of TCP was added to 1 mL of deionised 
water, and 2.00 mg of TAMORF was added to 1 mL 
of glycerol formal (purum grade, Fluka, Switzerland). 
Solutions were shaken in an ultrasonic bath (Branson 
5210, Bransonic, USA) for 10 min. An aliquot was 
Figure 1  Structural formula of tenocyclidine (TCP),
1-[1-(2-thienyl)cyclohexyl]piperidine
Figure 2   Structural formula of TAMORF,
1-[2-(2-thienyl)-2-adamantyl] morpholin 
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added to 1.5 mL of rat urine, and the mixtures shaken 
in the ultrasonic bath (Branson 5210, Bransonic, 
USA) for another 10 min. One millilitre of chloroform 
was then added to urine solutions, and the mixtures 
centrifuged (EBA, Hettich, USA,) for 5 min at 
2500 rpm. Chloroform phases were put into analytical 
vials and analysed with GC-MS.
Animals
Male adult Wistar rats were obtained from the 
Institute for Medical Research and Occupational 
Health (Zagreb, Croatia) and selected by mass (240 g 
to 280 g). The animals were kept in macrolone cages 
under controlled conditions (room temperature 21 °C, 
12 h : 12 h light:dark cycle), received a standard diet 
for laboratory rodents (Sljeme, Zagreb, Croatia), and 
had free access to water. The rats were randomly 
distributed in groups of four and were deprived of 
food for 24 h before the experiment. The study was 
carried out according to the NIH Guide for the Care 
and Use of Laboratory Animals (19). The experiments 
were approvedby the Intitute’s ethics committee and 
by the Ministry of Science, Education and Sports of 
the Republic of Croatia.
Treatment of animals
The first group was intraperitoneally (i.p.) 
administered TCP dissolved in deionised water in the 
concentration of 2.5 mg kg-1 body mass. The second 
group (negative control - water)  received an i.p. dose 
of deionised water (in a volume corresponding to that 
of the TCP solution administered to the ﬁ rst group). 
The third group received an i.p. dose of TAMORF 
dissolved in glycerol formal in the concentration of 
125 mg kg-1 body mass. The fourth group (negative 
control - saline) received an i.p. dose of saline (in 
a volume corresponding to that of the TAMORF 
solution administered to the third group). The ﬁ fth 
group (negative control - solvent) received an i.p. 
dose of glycerol formal (in a volume corresponding 
to that of the TAMORF solution administered to the 
third group).
Urine collection and analysis
Rat urine was collected over six hours after 
treatment and stored at 4 °C till analysis.
One millilitre of chloroform was added to 1.5 mL 
of collected urine and the mixture centrifuged at 
2500 rpm for 5 min. Chloroform phases were put into 
analytical vials and analysed with GC-MS.
GC-MS system and operational conditions
The GC-MS system consisted of  a gas 
chromatograph (Agilent Technologies 6890N Network 
GC System, USA), an Agilent 19091S-433 column 
(HP 5 MS, 30 m x 0.25 mm;  0.25 µm ﬁ lm thickness), 
helium as carrier gas (Helium 5.0, Messer, Austria), 
mass selective detector (Agilent Technologies 5973 
Network), a PC, and a printer. The initial temperature 
of the GC oven was 90 °C (for 6.00  min) and the 
ﬁ nal temperature was 295 °C (for 10.00  min). The 
temperature rate was 15 °C min-1, injector temperature 
295 °C, mode of injection splitless, and carrier gas 
flow 1.5 mL min-1. The run time was 29.67 min. 
Solvent delay was 4.00 min, temperature of the 
interface 295 °C, the acquisition mode was full scan 
and the scanning rate was 40.00 m/z to 550.00 m/z, MS 
source temperature 230 °C, and the MS quadrupole 
temperature 150 °C. “Wiley275”, “NIST02”, and 
“PMW_TOX3” MS libraries were used.
RESULTS AND DISCUSSION
Mass spectra of TCP and TAMORF
Figure 3 shows the mass spectra of pure TCP and 
TAMORF powders.
Figure 3 Mass spectra of TCP and TAMORF
GC-MS chromatograms of standard chloroform 
solutions of TCP and TAMORF
Total ion current (TIC) chromatogram of the 
standard chloroform solution of TCP showed two 
signals (Figure 4). The analysis of the mass spectra 
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and by their 
comparison with the mass spectra database showed 
that the signal t
1
 corresponded to 1-thienylcyclohexene 
(Figure 5), and the signal t
2
 to TCP (Figure 3). In 
other words, a part of TCP dissolved in chloroform 
remained unchanged and a part decomposed to 1-
thienylcyclohexene. Structurally, thienylcyclohexene 
is TCP without the piperidine ring.
compounds by retention times. No signal matches 
were found in the mass specta database, which means 
that mass spectra of TAMORF and/or compounds to 
which it decomposes when dissolved in chloroform do 
not exist in common mass spectra databases.










216, 161, 97, 175, 128
t
2
218, 97, 79, 123, 135
t
3
217, 97, 111, 79, 151 
t
4
111, 234, 217, 201, 150
Figure 4  GC-MS chromatogram of TCP dissolved in 
chloroform
Figure 5  Mass spectrum of compound t
1
 from Figure 4 and 
mass spectrum of thienylcyclohexene from mass 
spectra database
The TIC chromatogram of TAMORF standard 
solution (Figure 6) showed that TAMORF dissolved 
in chloroform decomposes to four compounds with 




. Table 1 shows the 
ﬁ ve most abundant signals from the mass spectra of 
Figure 6  GC-MS chromatogram of TAMORF dissolved in 
chloroform
GC-MS chromatograms of TCP and TAMORF 
dissolved in urine 
TIC chromatograms of TCP and TAMORF 
dissolved in urine showed signals at the same retention 
times as TIC chromatograms of these compounds 
dissolved in chloroform (Figures 4 and 6). The mass 
spectra of TCP and TAMORF dissolved in urine were 
equal to TCP and TAMORF dissolved in chloroform, 
which suggests that both TCP and TAMORF have 
the same decomposition pattern when dissolved in 
chloroform and urine.
TIC chromatograms of urine extract of rats treated 
with TCP and TAMORF
Figure 7 shows urine TIC chromatogram of urine 
extract of rats treated with TCP and the respective 
mass spectrum of a compound with signal at 
retention time t
1
. This mass spectrum corresponds to 
1-thienylcyclohexene (Figure 5). GC-MS analysis 
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shows that rat body metabolises TCP into the same 
compound into which it decomposes when dissolved 
in chloroform or urine.
Figure 8  TIC chromatograms of urine extract of rats treated 
with TAMORF (A), glycerol formal (B), and saline 
(C)
Figure 7  TIC chromatogram of urine extract of rats treated 
with TCP (a) and mass spectrum of a compound t
1 
(b)
Figure 8 shows TIC chromatograms of urine extract 
of rats treated with TAMORF and controls (treated 
with glycerol formal and saline). The chromatogram 
of urine extract of rats treated with TAMORF (A) 
differs from the other two chromatograms (B and 
C) in ten signals. Rats treated with glycerol formal 





as rats treated with TAMORF (A), but their mass 





of the chromatograms shown in Figure 8A and 8B 





 from the chromatogram in Figure 
8A originate from TAMORF excreted in rat urine. 
To verify that, we compared the chromatogram in 
Figure 8A with the chromatogram of TAMORF 
dissolved in chloroform or in urine (Figure 6). Both 





and they correspond to the same mass spectra (see 
Table 1). Furthermore, TIC chromatogram of urine 
extract of rats treated with TAMORF also has signals 




 (Figure 8A), which correspond 
to the mass spectra signals in Table 2.
Again we found no matches between the mass 





 and the mass spectra databases.





 originate from TAMORF which 
passed unchanged through rat body and decomposed 
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in rat urine the same way it did when it was dissolved 
in chloroform or in urine (Figure 6). In contrast, the 





, which do not correspond to any standard 
TAMORF solution signal. This suggests that a part of 
TAMORF was metabolised in the rats’ body.
CONCLUSION
Our newly developed GC-MS method has been 
successful in establishing TCP and TAMORF 
decomposition in chloroform and rat urine, and TCP 
elimination via rat urine.
TCP dissolves well in water, chloroform, and rat 
urine. When dissolved, part or it remains unchanged, 
and part decomposes to 1-thienylcyclohexene. In our 
experiment all of TCP was metabolised in rats six 
hours after treatment. Further research should reveal 
how long rat body takes to completely decompose 
TCP, that is,  for how long TCP remains active in 
rats.
TAMORF dissolves well in chloroform and 
glycerol formal and decomposes to four compounds, 
whose structure is yet to be determined by future 
studies. In rat urine, we found six TAMORF 
metabolites (also to be identiﬁ ed in future studies), 
which leads to the conclusion that six hours after 
administration, TAMORF can still be active.
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Sažetak
KVALITATIVNA PROCJENA ELIMINACIJE TCP-A I TAMORF-A IZ ORGANIZMA ŠTAKORA 
METODOM GC-MS
Živčani bojni otrovi po strukturi su organofosforni (OP) spojevi, čija je zajednička značajka ireverzibilna 
inhibicija acetilkolinesteraze (AChE), enzima koji hidrolizira acetilkolin (ACh) u živčanom sustavu. 
Patoﬁ ziološka zbivanja koja nastaju pri otrovanju OP-spojevima primarno su posljedica akumuliranog ACh 
na kolinergičkim receptorima i u središnjem živčanom sustavu. Još uvijek nesavršen, standardni tretman 
liječenja otrovanja OP-spojevima uključuje kombiniranu primjenu estera karbamata, atropina, oksima i 
antikonvulziva. Kako bi se unaprijedila uobičajena terapija, osobito kod otrovanja somanom, ispituju se 
antidotski učinci mnogih spojeva. Tenociklidin (TCP) i njegov adamantanski derivat TAMORF pokazali 
su zanimljiva svojstva pomoćne terapije pri otrovanju somanom. Kako bi se proširile dosadašnje spoznaje 
o načinu na koji tenociklidini štite organizam od trovanja OP-spojevima te također o trajanju njihova 
antidotskog učinka, u ovom radu razvijena je GC-MS-metoda za praćenje eliminacije TCP-a i TAMORF-a 
iz organizma. Rezultati GC-MS-analize pokazali su da šest sati nakon tretiranja štakora TCP-om mokraće 
sadržavaju metabolit TCP-a 1-tienilcikloheksen, dok šest sati nakon tretiranja štakora TAMORF-om 
mokraće sadržavaju i TAMORF i njegove metabolite. Drugim riječima, šest sati nakon tretmana TCP se 
potpuno metabolizira, dok se TAMORF metabolizira djelomično, a djelomično ostaje nepromijenjen.
KLJUČNE RIJEČI: antidot, kvalitativna metoda, metabolit, mokraća, tenociklidin
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